These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9160676)

  • 1. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy.
    Fearnley DB; McLellan AD; Mannering SI; Hock BD; Hart DN
    Blood; 1997 May; 89(10):3708-16. PubMed ID: 9160676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competent dendritic cells derived from CD34+ progenitors express CMRF-44 antigen early in the differentiation pathway.
    Monji T; Petersons J; Saund NK; Vuckovic S; Hart DN; Auditore-Hargreaves K; Risdon G
    Immunol Cell Biol; 2002 Jun; 80(3):216-25. PubMed ID: 12067408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability.
    Piemonti L; Monti P; Zerbi A; Balzano G; Allavena P; Di Carlo V
    Cancer Immunol Immunother; 2000 Dec; 49(10):544-50. PubMed ID: 11129325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMRF-56 immunoselected blood dendritic cell preparations activated with GM-CSF induce potent antimyeloma cytotoxic T-cell responses.
    Freeman JL; Vari F; Hart DN
    J Immunother; 2007 Oct; 30(7):740-8. PubMed ID: 17893566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.
    Hock BD; Starling GC; Daniel PB; Hart DN
    Immunology; 1994 Dec; 83(4):573-81. PubMed ID: 7875738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.
    Morse MA; Zhou LJ; Tedder TF; Lyerly HK; Smith C
    Ann Surg; 1997 Jul; 226(1):6-16. PubMed ID: 9242332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
    Ratta M; Curti A; Fogli M; Pantucci M; Viscomi G; Tazzari P; Fagnoni F; Vescovini R; Sansoni P; Tura S; Lemoli RM
    Exp Hematol; 2000 Aug; 28(8):931-40. PubMed ID: 10989194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro.
    Chen B; Shi Y; Smith JD; Choi D; Geiger JD; Mulé JJ
    Blood; 1998 Jun; 91(12):4652-61. PubMed ID: 9616162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.
    Kiertscher SM; Roth MD
    J Leukoc Biol; 1996 Feb; 59(2):208-18. PubMed ID: 8603993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on induction of dendritic cells from myeloid leukemia cell lines and their antitumor immune function].
    Luo YP; Li YG; Cai DC; Ren H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):229-35. PubMed ID: 12513792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor.
    Brossart P; Grünebach F; Stuhler G; Reichardt VL; Möhle R; Kanz L; Brugger W
    Blood; 1998 Dec; 92(11):4238-47. PubMed ID: 9834229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics.
    Oehler L; Majdic O; Pickl WF; Stöckl J; Riedl E; Drach J; Rappersberger K; Geissler K; Knapp W
    J Exp Med; 1998 Apr; 187(7):1019-28. PubMed ID: 9529318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56.
    Hock BD; Fearnley DB; Boyce A; McLellan AD; Sorg RV; Summers KL; Hart DN
    Tissue Antigens; 1999 Apr; 53(4 Pt 1):320-34. PubMed ID: 10323336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression.
    Bernhard H; Huseby ES; Hand SL; Lohmann M; Batten WY; Disis ML; Gralow JR; Meyer zum Büschenfelde KH; Ohlén C; Cheever MA
    Immunobiology; 2000 Apr; 201(5):568-82. PubMed ID: 10834314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of vitamin A on the differentiation, maturation and functions of dendritic cells from cord blood].
    Tao YH; Yang Y
    Zhonghua Er Ke Za Zhi; 2004 May; 42(5):340-3. PubMed ID: 15189689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
    Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
    Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cells.
    Hauss P; Selz F; Cavazzana-Calvo M; Fischer A
    Eur J Immunol; 1995 Aug; 25(8):2285-94. PubMed ID: 7545116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.